Aetna Streamlines Cancer Treatment Preapprovals
CVS Health unit Aetna announced plans to cut back cancer treatment preapprovals to a single medical prior authorization process starting next year. The bundled process aims to reduce administrative burdens for healthcare providers.
Insights:
CVS Health's Aetna will cut cancer treatment preapprovals next year to a single process, reducing administrative burdens for providers in the United States. The insurer announced the overhaul on Thursday, shifting from separate sign-offs for chemotherapy, imaging, and radiation. The move places Aetna alongside rival health plans streamlining outlays for oncology care.
